NASDAQ:TLPH Talphera (TLPH) Stock Price, News & Analysis → Bible Shocker: Have You Seen Elon Musk’s Miracle? (From InvestorPlace) (Ad) Free TLPH Stock Alerts $1.08 -0.07 (-6.09%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range$1.08▼$1.1750-Day Range$0.93▼$1.2252-Week Range$0.43▼$1.61Volume42,135 shsAverage Volume78,830 shsMarket Capitalization$18.35 millionP/E RatioN/ADividend YieldN/APrice Target$4.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Get Talphera alerts: Email Address Talphera MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside316.7% Upside$4.50 Price TargetShort InterestHealthy0.90% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.50Based on 14 Articles This WeekInsider TradingN/AProj. Earnings GrowthDecreasingFrom ($0.84) to ($1.03) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.42 out of 5 starsMedical Sector722nd out of 914 stocksPharmaceutical Preparations Industry337th out of 427 stocks 3.5 Analyst's Opinion Consensus RatingTalphera has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageTalphera has only been the subject of 2 research reports in the past 90 days.Read more about Talphera's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.90% of the float of Talphera has been sold short.Short Interest Ratio / Days to CoverTalphera has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Talphera has recently increased by 38.57%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldTalphera does not currently pay a dividend.Dividend GrowthTalphera does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TLPH. Previous Next 2.5 News and Social Media Coverage News SentimentTalphera has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 14 news articles for Talphera this week, compared to 13 articles on an average week.Search InterestOnly 2 people have searched for TLPH on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.MarketBeat Follows3 people have added Talphera to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Talphera insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.00% of the stock of Talphera is held by insiders.Percentage Held by InstitutionsOnly 37.67% of the stock of Talphera is held by institutions.Read more about Talphera's insider trading history. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Talphera are expected to decrease in the coming year, from ($0.84) to ($1.03) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Talphera is -1.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Talphera is -1.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTalphera has a P/B Ratio of 1.13. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Talphera's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Banyan Hill PublishingCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.Click on Adam's shiny forehead for more details. About Talphera Stock (NASDAQ:TLPH)Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.Read More TLPH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TLPH Stock News HeadlinesMay 19 at 3:32 AM | americanbankingnews.comHC Wainwright Reiterates "Buy" Rating for Talphera (NASDAQ:TLPH)May 17 at 10:44 PM | msn.comTalphera, Inc. (NASDAQ:TLPH) Q1 2024 Earnings Call TranscriptMay 17 at 6:49 AM | americanbankingnews.comBrokers Offer Predictions for Talphera, Inc.'s Q2 2024 Earnings (NASDAQ:TLPH)May 16 at 9:42 PM | markets.businessinsider.comOptimistic Buy Rating for Talphera Despite Phase 3 Trial Enrollment DelayMay 16 at 5:45 PM | prnewswire.comTalphera to Participate at A.G.P. Virtual Healthcare ConferenceMay 15, 2024 | finance.yahoo.comTalphera Inc (TLPH) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances Amid ...May 14, 2024 | investorplace.comTLPH Stock Earnings: Talphera Beats EPS for Q1 2024May 14, 2024 | prnewswire.comTalphera Announces First Quarter 2024 Financial Results and Provides Corporate UpdateMay 13, 2024 | msn.comAcelRx Pharmaceuticals Q1 2024 Earnings PreviewMay 12, 2024 | americanbankingnews.comTalphera (TLPH) to Release Earnings on TuesdayMay 6, 2024 | msn.comMaxim Group Initiates Coverage of Talphera (TLPH) with Buy RecommendationMay 2, 2024 | prnewswire.comTalphera to Host First Quarter 2024 Financial Results Call and Webcast on Tuesday, May 14, 2024April 25, 2024 | finance.yahoo.comTalphera, Inc. (TLPH)April 13, 2024 | finance.yahoo.comTalphera, Inc. (TLPH) Stock Historical Prices & Data - Yahoo FinanceMarch 21, 2024 | msn.com5 years after it was yanked off stores, GOG's bringing underrated spy RPG Alpha Protocol in from the cold with fewer crashes and new achievementsMarch 20, 2024 | msn.comAlpha Protocol Finally Available Again Five Years After Being DelistedMarch 20, 2024 | seekingalpha.comTaysha: Initial Rett Syndrome Data Leads To Other 2024 CatalystsMarch 20, 2024 | msn.comCult classic spy RPG Alpha Protocol is back on PC after being delisted in 2019March 20, 2024 | msn.comAlpha Violet Propels ‘Identifying Features’ Directors’ Unconventional Sundance-Winning Cartel Narrative ‘Sujo’ to Cross Borders (EXCLUSIVE)March 20, 2024 | msn.comWolf Dogs vs. Alpha Academy stipulation match announced for next WWE NXTMarch 20, 2024 | msn.comAlpha Group: fintech reports growth as it eyes premium listing in 2024March 20, 2024 | msn.comUpcoming WWE NXT: Breakker and Corbin Team Up Against Alpha AcademyMarch 19, 2024 | msn.comMMOs collide as one fan recreates RuneScape using World of Warcraft assets, and after 9 months of work is getting close to an honest-to-god alpha buildMarch 19, 2024 | msn.comDonald Trump looks 'power-riddled' as he tries to be the 'alpha' in interview with Nigel FarageMarch 19, 2024 | finance.yahoo.comDubai-based Cryptocurrency Venture Capital 'Alpha Token Capital' Invests in $CVTXSee More Headlines Receive TLPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Talphera and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/06/2024Today5/19/2024Next Earnings (Estimated)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:TLPH Previous SymbolNASDAQ:TLPH CUSIPN/A CIK1427925 Webtalphera.com Phone650-216-3500Fax650-216-6500Employees15Year FoundedN/APrice Target and Rating Average Stock Price Target$4.50 High Stock Price Target$6.00 Low Stock Price Target$3.00 Potential Upside/Downside+316.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.89) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-18,400,000.00 Net MarginsN/A Pretax Margin-2,197.39% Return on Equity-96.30% Return on Assets-63.20% Debt Debt-to-Equity RatioN/A Current Ratio5.97 Quick Ratio2.56 Sales & Book Value Annual Sales$651,000.00 Price / Sales28.19 Cash FlowN/A Price / Cash FlowN/A Book Value$0.96 per share Price / Book1.13Miscellaneous Outstanding Shares16,993,000Free Float16,483,000Market Cap$18.35 million OptionableOptionable Beta0.46 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Vincent J. Angotti (Age 56)CEO & Director Comp: $906.54kDr. Pamela Pierce Palmer M.D. (Age 61)Ph.D., Co-Founder & Chief Medical Officer Comp: $699.75kMr. Raffi Mark Asadorian (Age 55)Chief Financial Officer Comp: $637.5kMr. Anil N. Dasu (Age 61)Chief Engineering Officer Comp: $478.09kKey CompetitorsSynlogicNASDAQ:SYBXAlaunos TherapeuticsNASDAQ:TCRTMEI PharmaNASDAQ:MEIPIndaptus TherapeuticsNASDAQ:INDPCocrystal PharmaNASDAQ:COCPView All Competitors TLPH Stock Analysis - Frequently Asked Questions Should I buy or sell Talphera stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Talphera in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" TLPH shares. View TLPH analyst ratings or view top-rated stocks. What is Talphera's stock price target for 2024? 2 analysts have issued 1 year price objectives for Talphera's stock. Their TLPH share price targets range from $3.00 to $6.00. On average, they predict the company's stock price to reach $4.50 in the next year. This suggests a possible upside of 316.7% from the stock's current price. View analysts price targets for TLPH or view top-rated stocks among Wall Street analysts. How have TLPH shares performed in 2024? Talphera's stock was trading at $0.7989 at the beginning of the year. Since then, TLPH shares have increased by 35.2% and is now trading at $1.08. View the best growth stocks for 2024 here. When is Talphera's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 8th 2024. View our TLPH earnings forecast. How were Talphera's earnings last quarter? Talphera, Inc. (NASDAQ:TLPH) issued its quarterly earnings results on Wednesday, March, 6th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.24) by $0.01. The firm earned $0.28 million during the quarter. How do I buy shares of Talphera? Shares of TLPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:TLPH) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressShocking $16T Elon Musk Crypto LeakCrypto 101 Media[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talphera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.